EE200000388A - Pharmaceutical composition containing micelles containing lipophilic glucocorticosteroid and only one surfactant - Google Patents

Pharmaceutical composition containing micelles containing lipophilic glucocorticosteroid and only one surfactant

Info

Publication number
EE200000388A
EE200000388A EEP200000388A EEP200000388A EE200000388A EE 200000388 A EE200000388 A EE 200000388A EE P200000388 A EEP200000388 A EE P200000388A EE P200000388 A EEP200000388 A EE P200000388A EE 200000388 A EE200000388 A EE 200000388A
Authority
EE
Estonia
Prior art keywords
surfactant
pharmaceutical composition
composition containing
lipophilic glucocorticosteroid
micelles
Prior art date
Application number
EEP200000388A
Other languages
Estonian (et)
Inventor
Sj�quist Gabrielle
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of EE200000388A publication Critical patent/EE200000388A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
EEP200000388A 1997-12-22 1998-12-22 Pharmaceutical composition containing micelles containing lipophilic glucocorticosteroid and only one surfactant EE200000388A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704833A SE9704833D0 (en) 1997-12-22 1997-12-22 New formulation
PCT/SE1998/002426 WO1999032089A1 (en) 1997-12-22 1998-12-22 Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant

Publications (1)

Publication Number Publication Date
EE200000388A true EE200000388A (en) 2002-02-15

Family

ID=20409536

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000388A EE200000388A (en) 1997-12-22 1998-12-22 Pharmaceutical composition containing micelles containing lipophilic glucocorticosteroid and only one surfactant

Country Status (20)

Country Link
EP (1) EP1043973A1 (en)
JP (1) JP2001526210A (en)
KR (1) KR20010024789A (en)
CN (1) CN1283106A (en)
AR (1) AR017220A1 (en)
AU (1) AU1993599A (en)
BR (1) BR9813811A (en)
CA (1) CA2315782A1 (en)
EE (1) EE200000388A (en)
HU (1) HUP0102365A3 (en)
ID (1) ID26945A (en)
IL (1) IL136880A0 (en)
NO (1) NO20003220L (en)
NZ (1) NZ505073A (en)
PL (1) PL341361A1 (en)
SE (1) SE9704833D0 (en)
SK (1) SK9532000A3 (en)
TR (1) TR200001977T2 (en)
WO (1) WO1999032089A1 (en)
ZA (1) ZA9811461B (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9902674D0 (en) * 1999-07-12 1999-07-12 Astra Ab New composition
SE0000332D0 (en) * 2000-01-31 2000-01-31 Astrazeneca Ab New use
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
SE0100901D0 (en) * 2001-03-15 2001-03-15 Astrazeneca Ab New composition
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
CA2536283A1 (en) * 2003-08-20 2005-03-03 Ajinomoto Co., Inc. Pharmaceutical preparations having an improved solubility
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
CN100579510C (en) * 2006-04-13 2010-01-13 新疆维吾尔自治区包虫病临床研究所 Precursor micelle preparation and its production process
MX349677B (en) * 2007-11-13 2017-08-08 Meritage Pharma Inc Corticosteroid compositions.
US9050368B2 (en) 2007-11-13 2015-06-09 Meritage Pharma, Inc. Corticosteroid compositions
WO2010029374A1 (en) * 2008-09-12 2010-03-18 Critical Pharmaceuticals Limited Improvements in the absorption of therapeutic agents across mucosal membranes or the skin
CN101982168B (en) * 2010-11-02 2012-05-23 山东大学 Quercetin nano-micelle preparation and preparation method thereof
CN102793678B (en) * 2011-05-26 2017-06-30 邓世明 A kind of preparation method of the Docetaxel injection without tween
DE102011108948A1 (en) * 2011-07-29 2013-01-31 Achim Göpferich Aqueous, colloidal solutions of lipophilic substances, in particular drug solutions
JP5456802B2 (en) * 2012-01-23 2014-04-02 株式会社Ｃａｃ Cell migration promoter and transdermal absorbent for wound treatment
WO2015008301A1 (en) * 2013-07-17 2015-01-22 Council Of Scientific & Industrial Research Pharmaceutical composition for the treatment of diminution of bone tissue
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
KR102086316B1 (en) * 2019-09-09 2020-03-09 한국콜마주식회사 Cosmetic composition having excellent percutaneous absorption property

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
US4994439A (en) * 1989-01-19 1991-02-19 California Biotechnology Inc. Transmembrane formulations for drug administration
SA95160463B1 (en) * 1994-12-22 2005-10-04 استرا أكتيبولاج powders for inhalation

Also Published As

Publication number Publication date
NO20003220L (en) 2000-08-22
NO20003220D0 (en) 2000-06-21
KR20010024789A (en) 2001-03-26
HUP0102365A3 (en) 2002-01-28
JP2001526210A (en) 2001-12-18
TR200001977T2 (en) 2000-12-21
SK9532000A3 (en) 2000-11-07
SE9704833D0 (en) 1997-12-22
BR9813811A (en) 2000-10-03
NZ505073A (en) 2002-09-27
AU1993599A (en) 1999-07-12
ZA9811461B (en) 1999-06-22
IL136880A0 (en) 2001-06-14
AR017220A1 (en) 2001-08-22
EP1043973A1 (en) 2000-10-18
WO1999032089A1 (en) 1999-07-01
HUP0102365A2 (en) 2001-11-28
PL341361A1 (en) 2001-04-09
ID26945A (en) 2001-02-22
CN1283106A (en) 2001-02-07
CA2315782A1 (en) 1999-07-01

Similar Documents

Publication Publication Date Title
EE200000388A (en) Pharmaceutical composition containing micelles containing lipophilic glucocorticosteroid and only one surfactant
NO20012915D0 (en) New pharmaceutical formulation
ID24654A (en) OMEPRAZOLA PHARMACEUTICAL FORMULATION
BR9810116B1 (en) solution composition and process for its preparation.
EE201000019A (en) Pharmaceutical compositions based on anticholinergic agents and
DZ2685A1 (en) Oral sustained release pharmaceutical formulation.
EE04144B1 (en) A pharmaceutical composition and its use
DE69726015D1 (en) PHARMACEUTICAL COMPOSITION CONTAINING KOENZYM Q-10
EE200000225A (en) Aryloxyalkyl dialkylamines, methods for their preparation and pharmaceutical composition
FI973828A (en) Compounds and compositions for administering the active ingredients
FI973475A (en) The composition and the product containing it
BR9808422B1 (en) compound, pharmaceutical composition, use of a compound, and process for the preparation of a compound.
DE69840097D1 (en) GRAIN DETERGENT COMPOSITIONS AND THEIR PREPARATION
EE200000226A (en) 3,6-Half-Ketals of the 9a-Azalides, Method of Preparation and Pharmaceutical Composition
IS5331A (en) New pharmaceutical mix
DE69820919D1 (en) Water-swellable compositions and sealants
EE03996B1 (en) Pharmaceutical compositions, process for their preparation and use
BR9709406B1 (en) substituted alkyloxyamino fluorenones and pharmaceutical composition containing them.
EE04260B1 (en) Pharmaceutical composition, process for its preparation and use
EE03387B1 (en) Combined pharmaceutical preparation, its use and method for its preparation
DE69512715D1 (en) ACONITIN SIMILAR COMPOUND AND ANTIPYRETICAL, ANALGETIC AND ANTI-INFLAMMATORY AGENT
ITFI940009A0 (en) TACHYCHININ ANTAGONISTS, THEIR PREPARATION AND PHARMACEUTICAL FORMULATIONS THAT CONTAIN THEM.
DE60000808T2 (en) Flowable pesticide oil-in-water formulations
ID23531A (en) PHARMACEUTICAL COMPOSITION
BR1100837A (en) Substituted 1-phenylpyrazol-3-carboxamides active on neurotensin, their preparation and pharmaceutical compositions containing them